|Post IPO Valuation|
|Series D, 10/2008 |
|Venture Round, 9/2009 ||$25M|
|Venture Round, 11/2009 ||$15M|
|Debt, 1/2013 ||$175M|
Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company’s operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.